Welcome to Therawis

Our mission is to combine highly innovative and novel diagnostics with effective therapeutics in oncology:

”The theranostic approach”

therascreen PITX2 RGQ PCR Kit (QIAGEN) is a novel clinically validated CE-IVD assay to determine the level of PITX2 methylation which helps predicting patient outcome to anthracycline-based chemotherapy and may help improve therapy decision-making.

Contact:

Therawis Pharma GmbH

Therawis Diagnostics GmbH

Grillparzerstrasse 14

81675 Munich Germany

Tel.: +49 (0) 89 41 42 45 57 0

Fax. +49 (0) 89 41 42 45 57 40

E-Mail: info@therawis.com

Website: http://www.therawis.com

 

Where to meet us:

< 2018 >
June
  • 14

    All day
    2018.06.14-2018.06.16

    40. Jahrestagung der Deutschen Gesellschaft für Senologie, 25.–27. Juni 2020, München

    Presenter: Prof. Kiechle

© 2018 Therawis - All Rights Reserved